A Snapshot of Sources of Coverage Among Medicare Beneficiaries
(By Gabrielle Clerveau, Nancy Ochieng, Juliette Cubanski, and Tricia Neuman for The Kaiser Family Foundation Published: Aug 14, 2023) Medicare
Read More
Medicaid
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read MoreCalifornia to eliminate asset tests for Medicaid
(By Rylee Wilson for Becker’s Hospital Review) CMS has approved a proposal from California to eliminate asset tests for Medicaid
Read MoreVirginia paid $21.8M for care for Medicaid enrollees that had already died, OIG audit finds
(By Rylee Wilson for Becker’s Hospital Review) Virginia made capitation payments for thousands of Medicaid enrollees after their deaths, an
Read MoreKFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go Without or Delay Care
(Contact Craig Palosky for the Kaiser Family Foundation published June 15, 2023) Most (58%) people with health insurance say they
Read MoreWeight loss drugs and CMS coverage: Why all eyes are on Medicare
(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read MoreWhy some physicians are breaking up with Medicare
(By Riz Hatton for Becker’s Hospital Review) Sixty-five percent of physicians plan to continue treating Medicare and Medicaid patients, according
Read MoreCBO: Uninsured rate to reach 10 percent by 2033
(By Rylee Wilson for Becker’s Hospital Review) More people will be uninsured in 2033 than in 2023 as Medicaid continuous
Read MoreCMS: Dual-eligible Medicare Advantage members less likely to receive cancer screenings, mental healthcare
(By Rylee Wilson for Becker’s Hospital Review) Individuals who are dually eligible for Medicare and Medicaid had lower scores on
Read MoreCMS proposes rules to improve Medicaid drug price transparency
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing a set of rules for drug manufacturers, pharmaceutical benefit managers
Read More